Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium bicarbonate 25meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Potassium bicarbonate+citric acid 1.39g/1.14g soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Potassium bicarbonate+potassium chloride effervescent tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Citric acid + potassium bicarbonate 2ns/2.5ns tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Product containing potassium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing potassium bicarbonate and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing potassium bicarbonate and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Potassium effervescent tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Product containing potassium bicarbonate and potassium bitartrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Potassium 6.5mmol effervescent tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
|
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing precisely potassium bicarbonate 2.5 gram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing potassium bicarbonate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Potassium bicarbonate- and sodium alginate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing potassium bicarbonate and potassium bitartrate in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Potassium bicarbonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Potassium bicarbonate and potassium bitartrate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing only potassium bicarbonate and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing only potassium bicarbonate and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing only potassium bicarbonate and potassium bitartrate in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing only potassium bicarbonate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
1 |
Product containing only potassium bicarbonate and sodium alginate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Citric acid and potassium bicarbonate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing citric acid and potassium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing only citric acid and potassium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing citric acid and potassium bicarbonate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium bicarbonate |
Inferred relationship |
Some |
2 |